Document is current
Any future updates will be listed below
-
Authors
Albarrán, Víctor
Guerrero, Patricia
de Quevedo, Coral García
González, Carlos
Chamorro, Jesús
Rosero, Diana Isabel
Moreno, Jaime
Calvo, Juan Carlos
de Aguado, Patricia Pérez
Alía, Víctor
Sotoca, Pilar
Barrill, Ana María
Román, María San
Álvarez-Ballesteros, Pablo
Serrano, Juan José
Soria, Ainara
Olmedo, María Eugenia
Saavedra, Cristina
Cortés, Alfonso
Gómez, Ana
Lage, Yolanda
Ruiz, Álvaro
Ferreiro, María Reyes
Longo, Federico
Garrido, Pilar
Gajate, Pablo
- License Information
-
More Information
Article History
Received: 24 March 2024
Accepted: 1 July 2024
First Online: 2 August 2024
Declarations
:
: CS declares speakers’ fees from Novartis and AstraZeneca. AC declares speakers’ and advisory fees from GlaxoSmithKline, AstraZeneca, PharmaMar, Daiichi Sankyo, MSD, Eisai and Accord Healthcare. PG (Garrido) declares speakers’ fees from Janssen, MSD, Novartis, Medscape, Takeda, TouchTime and Medscape and advisory fees from Abbvie, Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, GlaxoSmithKline, Janssen, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi and Takeda. PG (Gajate) declares advisory fees from BMS, Roche, Pfizer, Ipsen, MSD, Merck, Janssen, Astellas, Eisai and Novartis. The other authors declare no relevant conflicts of interest.
